209 related articles for article (PubMed ID: 8348033)
1. [The new antidepressant tetrindole].
Mashkovskiĭ MD; Glushkov RG; Shvedov VI; Andreeva NI; Golovina SM
Eksp Klin Farmakol; 1993; 56(2):3-6. PubMed ID: 8348033
[TBL] [Abstract][Full Text] [Related]
2. The new antidepressant pirlindole. A comparison with imipramine and tranylcypromine.
Martorana PA; Nitz RE
Arzneimittelforschung; 1979; 29(6):946-9. PubMed ID: 314808
[No Abstract] [Full Text] [Related]
3. [Anticalcium activity of several antidepressive agents].
Andreeva NI; Golovina SM; Rumiantsev EA; Mashkovskiĭ MD
Biull Eksp Biol Med; 1992 May; 113(5):502-4. PubMed ID: 1421269
[TBL] [Abstract][Full Text] [Related]
4. [Toxicological characteristics of the Soviet antidepressant pyrazidol].
Verstakova OL; Gerchikov LN; Sharova SA; Liberman SS
Farmakol Toksikol; 1985; 48(1):57-60. PubMed ID: 3979539
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino [3,2,1-j,k]carbazol hydrochloride (pirlindole), a new antidepressant.
Mashkovsky MD; Andrejeva NI
Arzneimittelforschung; 1981; 31(1):75-9. PubMed ID: 7194096
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibition by novel antidepressant tetrindole.
Medvedev AE; Kirkel AA; Kamyshanskaya NS; Moskvitina TA; Axenova LN; Gorkin VZ; Andreeva NI; Golovina SM; Mashkovsky MD
Biochem Pharmacol; 1994 Jan; 47(2):303-8. PubMed ID: 8304974
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
[TBL] [Abstract][Full Text] [Related]
9. [A comparative pharmacological study of the serotoninergic antidepressants tetrindole and fluoxetin].
Andreeva NI; Golovina SM; Parimbetova RB; Mashkovskiĭ MD
Eksp Klin Farmakol; 1996; 59(4):5-7. PubMed ID: 9026192
[TBL] [Abstract][Full Text] [Related]
10. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
[TBL] [Abstract][Full Text] [Related]
11. [Study of the mechanism of action of the new antidepressant pyrazidol].
Mashkovskiĭ MD; Gorkin VZ; Andreeva NI; Verevkina IV; Siniukhin VN
Farmakol Toksikol; 1975; 38(5):531-6. PubMed ID: 1183581
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
[TBL] [Abstract][Full Text] [Related]
13. [Effect of piracetam on the action of antidepressants (experimental data)].
Mashkovskiĭ MD; Andreeva NI; Parshin VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):129-31. PubMed ID: 2728714
[TBL] [Abstract][Full Text] [Related]
14. [Effects of antidepressive agents on tolerance of hypoxia and physical exercise].
Andreeva NI; Golovina SM; Parshin VA; Mashkovskiĭ MD
Biull Eksp Biol Med; 1991 Aug; 112(8):156-8. PubMed ID: 1786375
[TBL] [Abstract][Full Text] [Related]
15. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
[TBL] [Abstract][Full Text] [Related]
16. [Interaction of antidepressants and anticonvulsants in anticonvulsive and anti-reserpine tests].
Andreeva NI; Golovina SM; Mashkovskiĭ MD
Biull Eksp Biol Med; 1986 May; 101(5):566-8. PubMed ID: 3085742
[TBL] [Abstract][Full Text] [Related]
17. [The effect of pyrazidol and inkazan on the rotation behavior of rats].
Mashkovskiĭ MD; Bogdanov MB; Bondarenko NA
Farmakol Toksikol; 1989; 52(6):29-32. PubMed ID: 2625142
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of pirlindole, a selective RIMA, and its two enantiomers using biochemical and behavioural techniques.
Bruhwyler J; Liégeois JF; Gérardy J; Damas J; Chleide E; Lejeune C; Decamp E; de Tullio P; Delarge J; Dresse A; Géczy J
Behav Pharmacol; 1998 Dec; 9(8):731-7. PubMed ID: 9890262
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration].
Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
Biull Eksp Biol Med; 1985 May; 99(5):583-4. PubMed ID: 4005414
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological properties of sydnophen].
Al'tshuler RA; Mashkovskiĭ MD; Roshchina LF
Farmakol Toksikol; 1972 Jul; 35(4):406-10. PubMed ID: 4403203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
